INM-004 is under clinical development by Inmunova and currently in Phase III for Typical Hemolytic Uremic Syndrome (Shiga-Toxin Associated Hemolytic Uremic Syndrome). According to GlobalData, Phase ...
The Health Ministry has reported an unusual outbreak of a rare syndrome called "Hemolytic Uremic Syndrome" (HUS), which causes the destruction of red blood cells, clotting disorders, and kidney ...
An FDA inspection report shows that Taylor Farms violated food safety regulations at the Colorado plant that processed slivered onions linked to a deadly ...
Hemolytic uremic syndrome (HUS) is a rare disease that is clinically characterized by microangiopathic hemolytic anemia, thrombocytopenia and acute renal failure. 1 Although most childhood cases ...
Eculizumab is under clinical development by Alexion Pharmaceuticals and currently in Phase III for Coronavirus Disease 2019 (COVID-19) Associated Acute Lung Injury.